PANORAMIC Trial Collaborative Group, Butler, C C, Hobbs, F D R, Gbinigie, O A, Rahman, N M, Hayward, G, Richards, D B, Dorward, J, Lowe, D M, Standing, J F, Breuer, J, Khoo, S, Petrou, S, Hood, K, Nguyen-Van-Tam, J S, Patel, M G, Saville, B R, Marion, J, Ogburn, E, Allen, J, Rutter, H, Francis, N, Thomas, N P B, Evans, P, Dobson, M, Madden, T-A, Holmes, J, Harris, V, Png, M E, Lown, M, van Hecke, O, Detry, M A, Saunders, C T, Fitzgerald, M, Berry, N S, Mwandigha, L, Galal, U, Mort, S, Jani, B D, Hart, N D, Ahmed, H, Butler, D, McKenna, M, Chalk, J, Lavallee, L, Hadley, E, Cureton, L, Benysek, M, Andersson, M, Coates, M & Barrett, S 2023, ' Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial ', The Lancet, vol. 401, no. 10373, pp. 281-293 . https://doi.org/10.1016/S0140-6736(22)02597-1
2019, ' Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer : the prospective Streamline C trial ', The Lancet Gastroenterology & Hepatology, vol. 4, no. 7, pp. 529-537 . https://doi.org/10.1016/S2468-1253(19)30056-1 The Lancet. Gastroenterology & Hepatology
Taylor, S A, Mallett, S, Ball, S, Beare, S, Bhatnagar, G, Bhowmik, A, Boavida, P, Bridgewater, J, Clarke, C S, Duggan, M, Ellis, S, Glynne-Jones, R, Goh, V, Groves, A M, Hameeduddin, A, Janes, S M, Johnston, E W, Koh, D M, Lock, S, Miles, A, Morris, S, Morton, A, Navani, N, Oliver, A, O'Shaughnessy, T, Padhani, A R, Prezzi, D, Punwani, S, Quinn, L, Rafiee, H, Reczko, K, Rockall, A G, Russell, P, Sidhu, H S, Strickland, N, Tarver, K, Teague, J, Halligan, S, Evans, R, Shahabuddin, K, Jannapureddy, R, Mills-Baldock, T, Barhate, K, Nagy, Z, Raouf, S, Rich, N, Loke, T K, Gourtsoyianni, S & Kelly-Morland, C & Jalloh, A 2019, ' Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer : the prospective Streamline L trial ', The Lancet Respiratory Medicine, vol. 7, no. 6, pp. 523-532 . https://doi.org/10.1016/S2213-2600(19)30090-6